Administrative Team

Mark Andersen

Mark Andersen, CPA, CFA

Chief Financial Officer, Vice President of Administration

Mark Andersen

Mark Andersen, CPA, CFA

Chief Financial Officer, Vice President of Administration

Mark Andersen, CFA and CPA, most recently served as Vice President Finance and Corporate Controller for a biomedical company in Georgia. In that role, he was responsible for SEC reporting, mergers and acquisitions valuations and diligence, accounts payable, payroll, controls, and the employee retirement plan.

Previously, Andersen held multiple financial leadership roles at Eli Lilly and Company, including Investments Director for the company’s pension plan, where he managed highly diversified investment portfolios totaling approximately $13 billion in assets. He also served as Finance Director for Mergers & Acquisitions, where he completed acquisitions of both domestic and international businesses, and provided financial leadership and negotiation support for licensing and business development transactions. As Finance Director and Controller for Lilly USA, Andersen led the financial planning and analysis team of Lilly's U.S. sales and marketing affiliate with more than $10 billion in annual sales, and served as its financial controller with oversight for accounting and internal controls. He started his career in public accounting as an auditor with firms KPMG and Deloitte.

Andersen received his Bachelor of Science degree in accounting and Master of Science in accountancy from Southern Utah University, graduating magna cum laude and with high distinction. He earned his MBA from the University of Michigan Ross School of Business.

Chereall DeBoest

Chereall DeBoest

Administrative Assistant/Office Manager

Chereall DeBoest

Chereall DeBoest

Administrative Assistant/Office Manager

Chereall DeBoest is an experienced administrative assistant who most recently worked for the IUPUI School of Public and Environmental Affairs. She served in the Dean’s office and helped coordinate major events including the graduation dinner and commencement ceremonies.

DeBoest previously worked for Riley Children’s Hospital supporting the Children’s Clinical Research Center and the Translational Research and Integrative Biology lab. In that role she also helped manage the Morris Green Physicians Research Fellows and Internships.

A graduate of Ben Davis High School, DeBoest is currently pursuing a bachelor’s degree in Public Health through Southern New Hampshire University.

Brian Fillenwarth

Brian Fillenwarth

Financial Controller

Brian Fillenwarth

Brian Fillenwarth

Financial Controller

Brian Fillenwarth is responsible for all financial, accounting and reporting activities for the IBRI.

Prior to joining IBRI, Fillenwarth spent five years as the Chief Financial Officer at Freije-RSC Engineered Solutions, a private subcontractor, service, and engineering corporation, where he was responsible for all financial reporting, risk management and treasury needs. During his tenure Fillenwarth managed the integration of accounting systems and payroll processes for an acquisition involving 75 employees.

From 2007 to 2011, Fillenwarth held the positions of Accounting Manager and then Controller at King Systems Corp., a medical device company, where his responsibilities included accurate and timely reporting of financial data and development of controls and policies, forecasting, and procedural improvements. Among his accomplishments was managing the finance team through the company’s transition from a family-run business to a subsidiary of a publicly traded company in the United Kingdom. Before this, Fillenwarth held controller and accounting management positions at various public and private companies within the service and real estate sectors.

Fillenwarth graduated from Purdue University with a degree in accounting and obtained his Indiana-issued Certified Public Accountant (CPA) license in 2003.

Stephanie Grinage

Stephanie Grinage, MHA

Vice President for Advancement

Stephanie Grinage

Stephanie Grinage, MHA

Vice President for Advancement

Stephanie Grinage joined the Indiana Biosciences Research Institute (IBRI) as vice president for Advancement in June 2018. She serves as the primary strategic partner in cultivating and maintaining new and existing relationships with major donors and oversees and manages all aspects of IBRI’s fundraising programs.

Prior to IBRI she served as associate vice chancellor for Medical Advancement and associate dean for the University of Illinois at Chicago (UIC) College of Medicine where she directed all advancement activities across the College of Medicine campuses to maximize private philanthropy. Prior to UIC, she served in fundraising positions as KU Endowment’s vice president for Medical Development supporting the University of Kansas Medical Center; associate vice president for the University of South Florida/USF Health, and in leadership development positions with Arizona State University and Wichita State University.

Stephanie is a veteran of three significant endowment campaigns: the $1 billion Campaign Illinois initiative, the Campaign for Leadership at Arizona State University, and the $1.2 billion, “Far Above: The Campaign for Kansas”. During her tenure at KU Endowment, she was a member of the team that created the KU Institute for Advancing Medical Innovation, a model for philanthropy, industry and academia to collaborate in advancing university innovations in the life sciences. Most recently, she was instrumental in launching the $750 million IGNITE campaign for UIC.

She earned her Master's of Health Administration (MHA) from the University of Illinois-Chicago and received her Bachelor of Arts degree in communications from Fort Hays State University in Hays, Kan. She also attended Arizona State University in Tempe, Ariz.

Aimee Kappes

Aimee Kappes

IU Research Administrator

Aimee Kappes

Aimee Kappes

IU Research Administrator

Aimee Kappes is responsible for the sponsored research administration activities at IBRI, focusing primarily on pre-award services. She oversees the administrative and budgetary components of the proposal preparation process, collaborating with researchers to develop funding requests for their research programs.  

She also serves as the Business Research Administrator at the Clinical and Translational Sciences Institute at the Indiana University School of Medicine, where she manages financial accounts, interfaces with sponsors and external partners, and collaborates with faculty and staff to prepare funding applications and manage their sponsored projects.

Prior to joining IBRI she worked at Purdue University holding multiple positions, most recently pre-award funding administrator and USDA account manager. She specialized in supervising the pre-award aspects of proposals for international projects, working closely with the department of International Programs in Agriculture and its global partners. She oversaw the post-award activities for USDA research funding including award review, cash management, subrecipient monitoring, cost share tracking, and financial reporting and compliance. She also focused on process improvement and implementation, representing the interests of the Ag Field Office during the University’s Transform Purdue initiative.

She is a certified Pre-award Research Administrator and earned her MBA from Purdue University. She holds a Bachelor of Science degree in Accounting and a Bachelor of Arts degree in English.

Jay McGill

Jay McGill, PhD

Chief Operating Officer

Jay McGill

Jay McGill, PhD

Chief Operating Officer

Jay McGill, PhD is Indiana Bioscience Research Institute's Chief Operating Officer (COO). Dr. McGill brings a strong background of industrial experience, operations, and working in innovation across the industrial-academic boundaries. Most recently, Dr. McGill served as senior Director at Eli Lilly and Company in Lilly Research Laboratories responsible for science and technology partnerships. In this role, Dr. McGill served as the interface between academic institutions and Lilly Research Labs as well as overseeing Lilly's portfolio of research-based public/private partnerships and consortium participation.

In 2012-2014, Dr. McGill was on assignment as a loaned executive with BioCrossroads where he held the title of Translational Scientific Officer. His responsibilities at BioCrossroads included the support of several initiatives at the Indiana Clinical and Translational Institute (Indiana CTSI) at the Indiana University School of Medicine. He also provided support in the creation of the Indiana Biosciences Research Institute. Dr. McGill also was instrumental in establishing the Indiana CTSI–Covance partnership for a Phase 1 Clinic within IU Hospital and played a critical role in creating the Strategic Pharma-Academic Research Consortium for Translational Medicine (SPARC). Dr. McGill served as the Chief Operations Officer and Treasurer for the Fairbanks Institute for Healthy Communities.

Previous to his assignment at BioCrossroads, Dr. McGill was the Senior Director of Research Business Operations where his responsibilities included oversight and management of all research-based (preclinical) collaborations, alliances, and outsourcing partners, including chemistry, in vitro and in vivo biology, preclinical ADME and toxicology. Dr. McGill also was responsible for the research quality and compliance organizations. From December 2010 to June 2012, he served as Interim COO of the Lilly China Research Development Center (LCRDC) in Shanghai, China. After Eli Lilly announced its intentions to create a research and development site in China, Dr. McGill led a team to identify a location, construct the facility and establish the operations for LCRDC, which opened in June 2012.

After receiving a Bachelor of Science degree in chemistry from the University of Georgia and a PhD in organic chemistry from Indiana University, Dr. McGill joined Eli Lilly and Company in 1990 as a Senior Scientist in the Chemical Process Development Group. In 1998, he joined the Discovery Chemistry Research and Technologies organization and held a number of positions including Head of the Custom Synthesis Lab, Director of the Discovery Chemistry Synthesis Group, Sr. Director – Global Chemistry Sourcing. In 2008, as part of reorganization within Lilly Research Laboratories, all of the research-based sourcing groups (chemistry, in vitro and in vivo biology, toxicology and ADME) were consolidated under Dr. McGill’s leadership as Senior Director, External Research Operations.

Dr. McGill has more than 25 years of experience in pharmaceutical research and development, research collaborations, and outsourcing management. He has been instrumental in creating and developing Eli Lilly’s collaborations in Asia and establishing operations to support an external network of research-based outsourcing partners and alliances. Dr. McGill is known for his leadership in the pioneering of novel and transformational partnership models.

Alan Palkowitz, PhD

Alan Palkowitz, PhD

President & CEO

Alan Palkowitz, PhD

Alan Palkowitz, PhD

President & CEO

Alan Palkowitz, PhD, started his career as the Indiana Bioscience Research Institute’s (IBRI) President and CEO in September 2020. Dr. Palkowitz has 30 years of experience in drug discovery and development in both industry and academia. He is passionate about translational research and is driven to build a world-class organization that catalyzes activities across the life sciences ecosystem.

In addition to his role at the IBRI, Dr. Palkowitz maintains his roles at the Indiana University (IU) School of Medicine as a senior research professor of medicine, where he directs the IUSM-Purdue TaRget Enablement to Accelerate Therapy Development for Alzheimer’s Disease (TREAT-AD) Center, and is a key contributor to the IU Precision Health Initiative’s chemical biology and biotherapeutics scientific pillar. The chemical biology and biotherapeutics scientific pillar seeks to better understand the cellular processes behind abnormal gene and protein activity to improve scientists’ ability to identify drug targets and develop precision therapeutics.

Prior to joining the faculty at the IU School of Medicine, Dr. Palkowitz served as the vice president of Discovery Chemistry Research and Technologies at Eli Lilly and Company, where he worked for 28 years. In his role as vice president, Dr. Palkowitz was responsible for the global small molecule drug discovery strategy and delivery of clinical candidates in disease areas including cancer, diabetes, immunology, pain and neurodegenerative disorders.

Additionally, Dr. Palkowitz has served on several prominent advisory committees, including most recently the National Institutes of Health's National Center for Advancing Translational Sciences Advisory Council and the National Academies of Sciences’ Board on Chemical Sciences and Technology. He has published numerous research articles and is an inventor on almost 60 US patents. Dr. Palkowitz obtained his PhD in synthetic organic chemistry from the Massachusetts Institute of Technology and his bachelor’s degree in chemistry from the University of California at Berkeley.

Jacob Smith

Jacob Smith

Director of Information Technology

Jacob Smith

Jacob Smith

Director of Information Technology

Jacob Smith is responsible for the development and implementation of laboratory information management systems and technical support for IBRI operations. He works closely with researchers to understand their processes and distill the data requirements to fuel the design of solutions that make the experimental data usable.

Smith served as Informatics Solution Architect at Dow AgroSciences for eight years before joining the IBRI. While there, he led the organizational change and technical aspects of transforming the data management between laboratories and genomics teams, enabling the generation of more information with greater quality and faster generation.

Previously, Smith was an independent consultant on Laboratory Information Management Systems (LIMS), working on projects at Dow AgroSciences, Dow Chemical, Eli Lilly and Merck.

Smith received his bachelor’s degree in physics and math from Wabash College.

Lisa Soard

Lisa Soard

Director of Communications and Engagement

Lisa Soard

Lisa Soard

Director of Communications and Engagement

Lisa Soard is a proven communicator with 18 years of communications experience writing about issues such as health care and life sciences, and making complex topics simple. In her role at the IBRI she directs communications, community and media relations, social media strategy and website activities.

Prior to arriving at the IBRI in November 2019, she served as Vice President at Reputation Partners, a Chicago-based strategic communications firm, where she worked with clients such as EY (formerly Ernst & Young), Simon Property Group, Surgical Care Affiliates and Tivity Health. Her signature accomplishments consist of large-scale social media strategies that have enhanced her clients market presence and communications plans that have raised awareness of her clients among their target audiences.

She received her Bachelor of Arts degree in journalism and mass communication, specializing in public relations, from Drake University in Des Moines, Iowa.

Natalie Stull

Natalie Stull

Manager, Facilities and Lab Operations

Natalie Stull

Natalie Stull

Manager, Facilities and Lab Operations

Natalie D. Stull is Manager, Facilities and Lab Operations for the Indiana Biosciences Research Institute’s Metabolic Phenotyping Core Facility. In that capacity she is charged with managing projects with multiple principal investigators from the IBRI and other research campuses with mouse and rat phenotyping services, as well as other facility and lab-related operations.

Stull joined IBRI to continue her lengthy career as a scientist and research analyst in laboratory settings. Most recently, she served as the Associate Consultant Scientist in the Clinical Diagnostic Laboratory, a CAP/CLIA lab in the Department of Experimental Pathology at Eli Lilly and Company. Prior to that engagement, Stull was a research analyst, technician and lab manager for 14 years (2001-2014) in the Wells Center for Pediatric Research for Indiana University’s School of Medicine. During that time she worked for Dr. Raghu Mirmira and managed the Islet Core.

From 1990 through 2001, Stull served as a research technician and lab coordinator at the Thomas Jefferson University and Hahnemann/MCP University in Philadelphia, Pennsylvania. It was during this time she honed her skills in rodent surgical techniques.

Stull has authored or co-authored 28 publications during her career, including six resulting from research conducted in collaboration with Dr. Mirmira at the Wells Center for Pediatric Research. Stull received her Bachelor’s of Science degree in biology from Indiana University.

View publications